NCT04732403 is a NA clinical trial of Patient Position in Ureteral Injury, sponsored by University of Arizona.

Who is sponsoring NCT04732403?

NCT04732403 is sponsored by University of Arizona.

What drugs are being tested in NCT04732403?

Interventions in NCT04732403: Patient Position.

What condition does NCT04732403 study?

NCT04732403 studies Ureteral Injury, Surgery--Complications.

Is NCT04732403 still recruiting?

NCT04732403 is currently completed. Last updated 1 November 2024.

Last reviewed 2024-11-01 · How we verify

NCT04732403

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ureteral Jets and Patient Positioning Study

Completed NA Last updated 1 November 2024

What this trial tests

NA trial testing Patient Position in Ureteral Injury in 91 participants. Completed in 1 March 2022.

Timeline

1 February 2021

Primary endpoint
28 February 2022

1 March 2022

Quick facts

Lead sponsor	University of Arizona
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	91
Start date	1 February 2021
Primary completion	28 February 2022
Estimated completion	1 March 2022
Sites	1 location across United States

Drugs / interventions tested

Patient Position

Conditions studied

Ureteral Injury — all drugs for Ureteral Injury →
Surgery--Complications — all drugs for Surgery--Complications →

Sponsor

University of Arizona

Who can join

Adults 18 to 89, female only, with Ureteral Injury or Surgery--Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to identify the relationship between patient position during surgery and time to confirmation of ureteral patency on cystoscopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Arizona trials

Trials by the same sponsor.

NCT04062890 — Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance · Phase 2 · withdrawn
NCT05569486 — Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain · NA · not yet recruiting
NCT05064111 — Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy · suspended
NCT06567899 — Mechanistic Underpinnings of Preeclampsia · not yet recruiting
NCT07254793 — Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04732403 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Arizona
Last refreshed: 1 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04732403.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing